CoChat

Identification of a PCSK9-LDLR disruptor peptide with in vivo function

Open access
Brousseau, Margaret E., Clairmont, Kevin B., Spraggon, Glen, Flyer, Alec N., Golosov, Andrei A., Grosche, Philipp, Amin, Jakal, Andre, Jerome, Burdick, Debra, Caplan, Shari, Chen, Guanjing, Chopra, Raj, Ames, Lisa, Dubiel, Diana, Fan, Li, Gattlen, Raphael, Kelly-Sullivan, Dawn, Koch, Alexander W., Lewis, Ian, Li, Jingzhou, Liu, Eugene, Lubicka, Danuta, Marzinzik, Andreas, Nakajima, Katsumasa, Nettleton, David, Ottl, Johannes, Pan, Meihui, Patel, Tajesh, Perry, Lauren, Pickett, Stephanie, Poirier, Jennifer, Reid, Patrick C., Pelle, Xavier, Seepersaud, Mohindra, Subramanian, Vanitha, Vera, Victoria, Xu, Mei, Yang, Lihua, Yang, Qing, Yu, Jinghua, Zhu, Guoming, Monovich, Lauren G. · 2022 · Cell Chemical Biology
Cited by 49

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates plasma low-density lipoprotein cholesterol (LDL-C) levels by promoting hepatic LDL receptor (LDLR) degradation. Therapeutic antibodies that disrupt PCSK9-LDLR binding reduce LDL-C concentrations and cardiovascular disease risk. The epidermal growth factor precursor homology domain A (EGF-A) of the LDLR serves as a primary contact with PCSK9 via a flat interface, presenting a challenge for identifying small molecule PCSK9-LDLR disruptors. We employ an affinity-based screen of 1013in vitro-translated macrocyclic peptides to identify high-affinity PCSK9 ligands that utilize a unique, induced-fit pocket and partially disrupt the PCSK9-LDLR interaction. Structure-based design led to molecules with enhanced function and pharmacokinetic properties (e.g., 13PCSK9i). In mice, 13PCSK9i reduces plasma cholesterol levels and increases hepatic LDLR density in a dose-dependent manner. 13PCSK9i functions by a unique, allosteric mechanism and is the smallest molecule identified to date with in vivo PCSK9-LDLR disruptor function.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.chembiol.2021.08.012

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 49

Metadata

Authors
Brousseau, M. E., Clairmont, K. B., Spraggon, G., Flyer, A. N., Golosov, A. A., Grosche, P., Amin, J., Andre, J., Burdick, D., Caplan, S., Chen, G., Chopra, R., Ames, L., Dubiel, D., Fan, L., Gattlen, R., Kelly-Sullivan, D., Koch, A. W., Lewis, I., Li, J., Liu, E., Lubicka, D., Marzinzik, A., Nakajima, K., Nettleton, D., Ottl, J., Pan, M., Patel, T., Perry, L., Pickett, S., Poirier, J., Reid, P. C., Pelle, X., Seepersaud, M., Subramanian, V., Vera, V., Xu, M., Yang, L., Yang, Q., Yu, J., Zhu, G., & Monovich, L. G.
Venue
Cell Chemical Biology
Publisher
Elsevier BV
Published
2022-02
Volume
29
Issue
2
Pages
249-258.e5
ISSN
  • 2451-9448 (ISSN-L)
  • 2451-9456
OpenAlex
W3199130489
Cited by
49
References
7
FWCI
6.99
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of a PCSK9-LDLR disruptor peptide with in vivo function. https://app.cochat.ai/papers/10.1016/j.chembiol.2021.08.012
The paper
Brousseau, M. E., Clairmont, K. B., Spraggon, G., Flyer, A. N., Golosov, A. A., Grosche, P., Amin, J., Andre, J., Burdick, D., Caplan, S., Chen, G., Chopra, R., Ames, L., Dubiel, D., Fan, L., Gattlen, R., Kelly-Sullivan, D., Koch, A. W., Lewis, I., . . . Monovich, L. G. (2022). Identification of a PCSK9-LDLR disruptor peptide with in vivo function. Cell Chemical Biology. https://doi.org/10.1016/j.chembiol.2021.08.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.